ASARINA PHARMA AB Aktie - Unternehmensdaten & Kurse - SE0011641794 | MoneyPeak

ASARINA PHARMA AB

Share · SE0011641794 · A2N6U6 (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float 71,46 %

Shares Float 16,18 M

Shares Outstanding 22,64 M

Company Profile for ASARINA PHARMA AB Share

Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.

Get up to date insights from finAgent about ASARINA PHARMA AB

Company Data

Name ASARINA PHARMA AB

Company Asarina Pharma AB (publ)

Website https://www.asarinapharma.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2N6U6

ISIN SE0011641794

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Peter Nordkild

Country Sweden

Currency SEK

Employees 0,0 T

Address Karolinska Institutet Science Park, 171 65 Solna

IPO Date 2018-09-24

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	ASAP.ST
Frankfurt	APS.F

More Shares

Investors who hold ASARINA PHARMA AB also have the following shares in their portfolio:

CA IMMO 17/25 CV Bond

Vardhman Holdings Limited Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025